[Antilymphocyte serum. II].
D000818:Animals; D000906:Antibodies; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D004285:Dogs; D004357:Drug Synergism; D005921:Glomerulonephritis / Q000139:chemically induced; D000882:Haplorhini; D006801:Humans; D006967:Hypersensitivity; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008231:Lymphopenia; D051379:Mice; D011506:Proteins / Q000037:antagonists & inhibitors; D051381:Rats; D013921:Thrombocytopenia / Q000139:chemically induced; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D011506:Proteins
Les sérums antilymphocytes. II.